Ac-Ile-Glu-Pro-Asp-pNA is a chromogenic substrate designed to release a detectable signal upon proteolytic cleavage. Its structured motif allows investigation of enzyme selectivity and catalytic rates. The acetylated N-terminus enhances peptide stability in assays. Applications include enzymology, kinetic modeling, and substrate profiling.
CAT No: C11096
CAS No:216757-29-8
Synonyms/Alias:Ac-Ile-Glu-Pro-Asp-PNA;216757-29-8;Ac-IEPD-PNA;N-Acetyl-Ile-Glu-Pro-Asp-p-nitroanilide;(4S)-4-[[(2S,3S)-2-acetamido-3-methylpentanoyl]amino]-5-[(2S)-2-[[(2S)-3-carboxy-1-(4-nitroanilino)-1-oxopropan-2-yl]carbamoyl]pyrrolidin-1-yl]-5-oxopentanoic acid;DTXSID60385103;Ac-IEPD-pNA (trifluoroacetate salt);SCHEMBL1645617;DTXCID70336126;HY-P3236;Acetyl-Ile-Glu-Thr-Asp-paranitroanilide;AS-86287;DA-70547;FA110813;CS-0173537;G76884;acetyl-isoleucyl-glutamyl-threonyl-aspartic acid-paranitroanilide;N-Acetyl-Ile-Glu-Pro-Asp-p-nitroanilide, >=97% (HPLC), powder;L-alpha-Asparagine, N-acetyl-L-isoleucyl-L-alpha-glutamyl-L-prolyl-N-(4-nitrophenyl)- (9CI);
1. High fat diet and GLP-1 drugs induce pancreatic injury in mice
3. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
4. The spatiotemporal control of signalling and trafficking of the GLP-1R
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.